209 related articles for article (PubMed ID: 24687888)
21. Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer.
Liu Y; Luo X; Hu H; Wang R; Sun Y; Zeng R; Chen H
PLoS One; 2012; 7(12):e51748. PubMed ID: 23284758
[TBL] [Abstract][Full Text] [Related]
22. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
[TBL] [Abstract][Full Text] [Related]
23. Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis.
Li M; Peng F; Li G; Fu Y; Huang Y; Chen Z; Chen Y
Oncotarget; 2016 Jun; 7(24):37226-37237. PubMed ID: 27191989
[TBL] [Abstract][Full Text] [Related]
24. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers.
You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B
J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.
Shiromizu T; Kume H; Ishida M; Adachi J; Kano M; Matsubara H; Tomonaga T
Sci Rep; 2017 Oct; 7(1):12782. PubMed ID: 28986585
[TBL] [Abstract][Full Text] [Related]
26. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray.
Murakoshi Y; Honda K; Sasazuki S; Ono M; Negishi A; Matsubara J; Sakuma T; Kuwabara H; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Shimahara M; Yasunami Y; Ino Y; Tsuchida A; Aoki T; Tsugane S; Yamada T
Cancer Sci; 2011 Mar; 102(3):630-8. PubMed ID: 21199170
[TBL] [Abstract][Full Text] [Related]
27. A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples.
Narumi R; Murakami T; Kuga T; Adachi J; Shiromizu T; Muraoka S; Kume H; Kodera Y; Matsumoto M; Nakayama K; Miyamoto Y; Ishitobi M; Inaji H; Kato K; Tomonaga T
J Proteome Res; 2012 Nov; 11(11):5311-22. PubMed ID: 22985185
[TBL] [Abstract][Full Text] [Related]
28. [Search for breast cancer-related biomarker proteins for drug discovery].
Nagano K
Yakugaku Zasshi; 2010 Dec; 130(12):1701-6. PubMed ID: 21139398
[TBL] [Abstract][Full Text] [Related]
29. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.
Yang Q; Bavi P; Wang JY; Roehrl MH
J Proteomics; 2017 Sep; 168():53-65. PubMed ID: 28669815
[TBL] [Abstract][Full Text] [Related]
30. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers.
Ang CS; Baker MS; Nice EC
Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566
[TBL] [Abstract][Full Text] [Related]
31. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
[TBL] [Abstract][Full Text] [Related]
32. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
[TBL] [Abstract][Full Text] [Related]
33. Proteomics for discovery of candidate colorectal cancer biomarkers.
Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
[TBL] [Abstract][Full Text] [Related]
34. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
[TBL] [Abstract][Full Text] [Related]
35. Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer.
Katsila T; Juliachs M; Gregori J; Macarulla T; Villarreal L; Bardelli A; Torrance C; Elez E; Tabernero J; Villanueva J
Clin Cancer Res; 2014 Dec; 20(24):6346-56. PubMed ID: 25324142
[TBL] [Abstract][Full Text] [Related]
36. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
37. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing.
LaPointe LC; Pedersen SK; Dunne R; Brown GS; Pimlott L; Gaur S; McEvoy A; Thomas M; Wattchow D; Molloy PL; Young GP
PLoS One; 2012; 7(1):e29059. PubMed ID: 22276102
[TBL] [Abstract][Full Text] [Related]
38. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
[TBL] [Abstract][Full Text] [Related]
39. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.
Lind GE; Danielsen SA; Ahlquist T; Merok MA; Andresen K; Skotheim RI; Hektoen M; Rognum TO; Meling GI; Hoff G; Bretthauer M; Thiis-Evensen E; Nesbakken A; Lothe RA
Mol Cancer; 2011 Jul; 10():85. PubMed ID: 21777459
[TBL] [Abstract][Full Text] [Related]
40. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
